Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation

July 3, 2018 updated by: University of South Florida

A Prospective Randomized Single Blinded Study of Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation

The purpose of this study is to investigate a promising strategy to improve maturation and patency rates following creation of AV fistulas and assess whether an anastomosis performed with Anastoclips (interrupted, nonpenetrating) would produce better maturation and/or patency than one performed with conventional suturing techniques.

Study Overview

Detailed Description

This will be a single blind (patient and dialysis center), prospective, randomized trial conducted at a single center. The study intervention will be randomization between conventional sutured anastomosis (Control group) and use of Anastoclips (Treatment group), which provide an interrupted closure without intimal penetration.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Tampa, Florida, United States, 33606
        • Tampa General Hospital
      • Tampa, Florida, United States, 33606
        • University of South Florida - South Tampa Campus
      • Tampa, Florida, United States, 33612
        • USF Health Carol and Frank Morsani Center for Advanced Healthcare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Requiring brachiocephalic fistula judged to be best option for access after vein mapping (Surgeons will be required to do 10 cases using Anastoclips prior to enrolling)
  • Able to provide informed consent in English or Spanish
  • Age 18 years or greater
  • With estimated life expectancy of 2 years or more
  • Able to comply with study procedures including all scheduled follow-up visits

Exclusion Criteria:

  • Unable to provide informed consent in English or Spanish
  • Age < 18 years
  • With pacemaker, IACD, or other permanent obstructive device on that side (a temporary tunneled dialysis catheter is not an exclusion)
  • Unable (or in surgeon's judgment a poor risk) to comply with study procedures and follow-up visits
  • With estimated life expectancy of less than 2 years
  • Females must be either:

    • Of non-childbearing potential, which is defined as post-menopausal (at least 12 months without menses prior to Treatment Day) or documented surgically sterile or post hysterectomy (at least 1 month prior to Treatment Day)
    • Or, of childbearing potential, in which case must have a negative urine pregnancy test at Treatment Day

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Conventional sutures
AV fistula creation with sutures
End-to-side anastomosis (of AV fistula) is to be constructed using sutures. The incision is to be irrigated and closed using Vicryl, Biosyn and skin glue.
Active Comparator: Anastoclips
AV fistula creation with clips
End-to-side anastomosis (of AV fistula) is to be constructed using clips. The incision is to be irrigated and closed using Vicryl, Biosyn and skin glue.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Time to loss of primary patency
Time Frame: one year post surgery
one year post surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to loss of secondary patency
Time Frame: one year post surgery
one year post surgery
Time to loss of assisted primary patency
Time Frame: one year post surgery
one year post surgery
Rate of functional maturation
Time Frame: one year post surgery
in patients on dialysis
one year post surgery
Time to functional maturation
Time Frame: one year post surgery
in patients on dialysis
one year post surgery
Rate of assumed maturation
Time Frame: one year post surgery
in patients not on dialysis
one year post surgery
Time to assumed maturation
Time Frame: one year post surgery
in patients not on dialysis
one year post surgery
Rate of complications
Time Frame: 30 days post surgery
thrombosis/thrombectomy, stenosis, skin erosion, limb swelling, steal syndrome, bleeding and hematoma formation at surgical site, surgical-site-related infection, access-related infection, rupture, revision
30 days post surgery
Rate of intervention
Time Frame: five years post surgery
to maintain patency
five years post surgery
Operative cost
Time Frame: duration of surgery
duration of surgery
Overall cost
Time Frame: time of surgery to time of hospital discharge (can range from 1 day to 1 week or more)
Overall cost of surgery itself defined as from surgery to point of hospital discharge, anticipated to be in days
time of surgery to time of hospital discharge (can range from 1 day to 1 week or more)
Time to loss of primary patency
Time Frame: 5 years post surgery
5 years post surgery
Time to loss of assisted primary patency
Time Frame: 5 years post surgery
5 years post surgery
Time to loss of secondary patency
Time Frame: 5 years post surgery
5 years post surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karl Illig, MD, University of South Florida

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 1, 2017

Primary Completion (Anticipated)

February 1, 2024

Study Completion (Anticipated)

August 1, 2024

Study Registration Dates

First Submitted

January 6, 2017

First Submitted That Met QC Criteria

January 17, 2017

First Posted (Estimate)

January 18, 2017

Study Record Updates

Last Update Posted (Actual)

July 6, 2018

Last Update Submitted That Met QC Criteria

July 3, 2018

Last Verified

October 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arteriovenous Fistula

Clinical Trials on AV Fistula creation with sutures

3
Subscribe